These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 985049)

  • 21. Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions.
    Capstick N
    Scott Med J; 1975; 20(1 SUPPL):45-8. PubMed ID: 1154013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial.
    Pecknold JC; Amin MM; Ban TA; Orbach L
    Psychopharmacol Bull; 1976 Jan; 12(1):24-5. PubMed ID: 1108078
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychomotor skills in depressed out-patients treated with L-tryptophan, doxepin, or chlorimipramine.
    Seppälä T; Linnoila M; Mattila MJ
    Ann Clin Res; 1978 Aug; 10(4):214-21. PubMed ID: 707970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression.
    Møller SE; Bech P; Bjerrum H; Bøjholm S; Butler B; Folker H; Gram LF; Larsen JK; Lauritzen L; Loldrup D
    J Affect Disord; 1990 Jan; 18(1):59-66. PubMed ID: 2136870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double blind test with mianserin versus chlorimipramine.
    Rapisarda V; Bongiorno G
    Adv Biochem Psychopharmacol; 1982; 32():141-9. PubMed ID: 6283807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies.
    Hale AS; Procter AW; Bridges PK
    Br J Psychiatry; 1987 Aug; 151():213-7. PubMed ID: 3690111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous chlorimipramine and depressive subtypes.
    Escobar JI; Teeter RR; Tuason VB; Schiele BC
    Dis Nerv Syst; 1976 Jun; 37(6):325-8. PubMed ID: 1277983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M; Luscombe DK; Jones RB; Beaumont G; Seldrup J; John V
    J Int Med Res; 1977; 5(1 Suppl):119-24. PubMed ID: 863081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M; Swedo SE; Leonard HL; Richter D; Rubinow DR; Potter WZ; Rapoport JL
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma prolactin concentrations in normal subjects and depressive patients following oral clomipramine.
    Jones RB; Luscombe DK; Groom GV
    Postgrad Med J; 1977; 53 Suppl 4():166-71. PubMed ID: 600893
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single versus divided daily dosages of clomipramine. Plasma concentration and clinical effect.
    Dencker SJ; Nagy A
    Acta Psychiatr Scand; 1979 Mar; 59(3):326-34. PubMed ID: 373391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments.
    Møller SE
    Acta Psychiatr Scand Suppl; 1985; 325():3-31. PubMed ID: 2418637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN; Sexena B; Gent M
    J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
    Ananth J
    J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma level studies with clomipramine (anafranil).
    Jones RB; Luscombe DK
    J Int Med Res; 1977; 5(1 Suppl):98-107. PubMed ID: 863094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of L-tryptophan to electroconvulsive treatment in endogenous depression. A double-blind study.
    Kirkegaard C; Møller SE; Bjørum N
    Acta Psychiatr Scand; 1978 Nov; 58(5):457-62. PubMed ID: 362831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.